Mari Numata-Nakamura, MD, PhD Ask a Question Refer Patient Mari Numata-Nakamura, MD, is a researcher at National Jewish Health. Dr. Numata-Nakamura is in the Division of Pulmonary, Critical Care and Sleep Medicine. Assistant Professor of Medicine Department of Medicine Division of Pulmonary, Critical Care & Sleep Medicine 5280 Top Doctors 2019 Previously a 5280 Top Doctor America’s Top Doctors 2015 — Castle Connolly, Medical, Ltd. Recognized in America’s Top Doctors — Castle Connolly, Inc. Best Doctors in America® 2018-2019 — Best Doctors, Inc. Recognized in Best Doctors in America® — Best Doctors, Inc. America’s Top Doctors 2019 — Castle Connolly Medical, Ltd. Email Profile Print Profile × No Rating Available In order to provide the most accurate and useful information on our providers, we only post satisfaction data when a provider has received a minimum of 30 survey responses. We have not yet received the minimum number of surveys for this provider, or this provider is a researcher who only sees a limited number of patients in clinic. To learn more about this survey, visit our about the Press Ganey Survey page. Close Overview Contact Info & Locations Programs & Services Department of Medicine Division of Pulmonary, Critical Care and Sleep Medicine (Adult) Research Areas Basic Immunology Inflammation Lung Cell Biology Mycobacterial and Respiratory Infections Pulmonary Medicine Allergy Special Interests Mari Numata-Nakamura has twenty years of experience as a clinical pulmonologist. She currently focuses on research investigating the role of pulmonary surfactant in regulating innate immunity in the lung, with special emphasis upon surfactant lipid antagonism of inflammation and viral infection. She discovered the anti-viral properties of the surfactant lipid palmitoyl-oleoyl-phophatidylglycerol (POPG). The long-term goals of her research are to bring basic research observations to treatment of patients. Education Education Yokohama City University School of Medicine, Yokohama, Japan, Residency Yokohama City University School of Medicine, Yokohama, Japan, Fellowship Yokohama City University School of Medicine, Yokohama, Japan, Awards & Recognition 2011: International Conference on Lung Innate Immunity and Pulmonology at ATS (i-CLIPP 2011), The i-CLIPP 2011 Peter Hansen Award for the Best Poster Presentation 2010: National Jewish Health 2010 Faculty awared, Outstanding Scientific Achievement in Basic Research (Nominees) 2009: American Thoracic Society Travel Award Grant, ATS Assembly of Microbiology, Tuberculosis and Pulmonary Infections, 2009 International Conference, San Diego, California 2008: American Thoracic Society Travel Award Grant, ATS Assembly on Microbiology, Tuberculosis and Pulmonary Infections, 2008 International Conference, Toronto, Canada Board Certification 2006: Japanese Society of Allergology 1998: Japanese Society of Respiratory Medicine 1998: Japanese Society of Internal Medicine Professional Memberships American Thoracic Society Japanese Society of Internal Medicine Japanese Respiratory Society Japanese Society of Allergology Publications Numata M, Chu HW, Dakhama A, Voelker DR: Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced inflammation and infection, Proceedings of the National Academy of Sciences of the United States of America. 2010.107:320-325. Numata M, Kandasamy P, Nagashima Y, Posey J, Hartshorn K, Woodland D and Voelker DR. Phosphatidylglycerol Suppresses Influenza A Virus Infection. Am J Respir Cell Mol Biol. 2012. 46:479–487. Numata M, Nagashima Y, Moore ML, Berry KZ, Chan M, Kandasamy P, Peebles SR Jr, Murphy RC and Voelker DR. Phosphatidylglycerol Provides Short Term Prophylaxis Against Respiratory Syncytial Virus Infection. The Journal of Lipid Research. 2013. 54: 2133–2143. Numata M, Yoji Nagashima, Pitchaimani Kandasamy, and Dennis R. Voelker. Pulmonary Surfactant Lipid, Phosphatidylinositol is a Novel Anti-Viral Compound for Treating Respiratory Syncytial Virus Infection. The Journal of Lipid Research. 2015. 56:578-87. Numata M, Voelker DR.: Asthma and Infections”. In: Martin RJ, Sutherland ER, eds. Lung Biology in Health and Disease. New York: Informa Healthcare. 2010:145-165. Chapter10: Pulmonary Surfactant. Innate Immunity and Asthma. Teaching & Professional Positions 2014-2015: Visiting Associate Professor of Medicine, Yokohama City University School, Yokohama, Japan 2014-2015: Department Head, Department of Respiratory Medicine, Omori Red Cross Hospital, Tokyo, Japan 2013-2014: Vice Head, Department of Respiaroty Medicine, Omori Red Cross Hospital, Tokyo, Japan 2012-2013: Assistant Professor of Medicine, Department of Medicine, National Jewish Health, Denver, CO 2009-2012: Instructor, Department of Medicine, National Jewish Health, Denver, CO 2002-2006: Senior Chief Physician, Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Kanagawa, Japan 2002-2003: Assistant Professor, Yokohama City University Medical Center, Critical Care and Medical Emergency Center, Yokohama, Japan Website Information Voelker Lab Ask a Question through Patient Portal Sign in to your My National Jewish Health patient portal account to communicate with your care team, manage appointments, and more. Create an Account Contact Information Office: 303.398.1298Fax: 303.398.1806 Email: firstname.lastname@example.org Patient Ratings The Patient Rating score is an average of all responses to care provider related questions on our independent rating system, the Press Ganey Patient Satisfaction Survey. This survey is about the patient care experience and does not address crucial characteristics like medical decision-making, prescribing the best therapy, and patient outcomes. Responses are measured on a scale of 1 to 5, with 5 being the best score. Learn more about our patient satisfaction survey. Comments Comments are collected in our Press Ganey Patient Satisfaction Surveys. Patients are de-identified to protect confidentiality and patient privacy. Learn more about our patient satisfaction survey.